Amalgamated Bank Amyris, Inc. Transaction History

Amalgamated Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.58 - $1.3 $286 - $642	494 Added 2.22%	22,755 $23,000
Q1 2023 May 02, 2023	SELL	$1.09 - $1.82 $3,846 - $6,422	-3,529 Reduced 13.68%	22,261 $30,000
Q3 2022 Nov 09, 2022	BUY	$1.7 - $4.05 $93 - $222	55 Added 0.21%	25,790 $75,000
Q2 2022 Aug 15, 2022	BUY	$1.6 - $5.07 $5,776 - $18,302	3,610 Added 16.32%	25,735 $48,000
Q1 2022 Jun 30, 2022	SELL	$3.92 - $5.86 $5,464 - $8,168	-1,394 Reduced 5.93%	22,125 $96,000
Q4 2021 Feb 15, 2022	BUY	$5.0 - $14.85 $1,340 - $3,979	268 Added 1.15%	23,519 $127,000
Q3 2021 Oct 29, 2021	SELL	$12.13 - $16.99 $13,767 - $19,283	-1,135 Reduced 4.65%	23,251 $319,000
Q2 2021 Aug 16, 2021	BUY	$10.82 - $19.37 $263,856 - $472,356	24,386 New	24,386 $399,000

230K

Ticker AMRS
Exchange NASDAQ
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 324,860,000
Market Cap $3.25M
Description
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.